We provide 1 form of Cabozantinib
Cabozantinib
849217-68-1
|
501.17
|
4.943
Cabozantinib is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer.
BMS-907351 | XL184 | cabozantinib | carbozantinib
Cabozantinib is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer.
BMS-907351 | XL184 | cabozantinib | carbozantinib
$67/5 mg
(EBC)
1
We provide 0 compound for Cabozantinib